Vincent Mutel
Vorstandsvorsitzender bei Inflamalps SA
Profil
Vincent Mutel was the founder of Addex Therapeutics Ltd.
(founded in 2002) where he held the title of Chief Executive Officer from 2002 to 2010.
He is also the founder of Inflamalps SA (founded in 2012) where he currently holds the title of Chairman & Chief Executive Officer.
Dr. Mutel's current job is as a Director at Metys Pharmaceuticals AG.
His former jobs include being a Non-Executive Director at Lectus Therapeutics Ltd., Head-Pharmacology at F.
Hoffmann-La Roche Ltd., Principal at Basel - SpA, and Principal at CRI Worldwide LLC.
Dr. Mutel obtained a doctorate degree from the University of Paris Jussieu in 1987.
Aktive Positionen von Vincent Mutel
| Unternehmen | Position | Beginn |
|---|---|---|
Inflamalps SA
 Inflamalps SA Pharmaceuticals: MajorHealth Technology Inflamalps SA operates as a biopharmaceutical company. The firm focuses on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology. The company was founded by Charles Woler, Vincent Mutel and Philippe Meuwly in August 2012 and is headquartered in Monthey, Switzerlands. | Vorstandsvorsitzender | 01.08.2012 |
Metys Pharmaceuticals AG
 Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Vincent Mutel
| Unternehmen | Position | Ende |
|---|---|---|
CRI Worldwide LLC
 CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services CRI Worldwide LLC engages in the provision of inpatient and outpatient clinical research services. It specializes in inpatient and outpatient clinical trials ranging from phase I to IV focusing on pediatrics, adolescents, adults, and elderly in the areas of acute and chronic pain, attention deficit hyperactivity disorder, Alzheimer’s disease, atypical depression, back pain, bipolar disorder, cancer pain, diabetes, epilepsy, fibromyalgia, general anxiety disorder, hepatitis, major depressive disorder, manic depression, migraines/headaches, mild cognitive impairment. The company was founded by Howard A. Hassman in 2000 and is headquartered in Mt. Laurel, NJ. | Corporate Officer/Principal | - |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Basel - SpA
 Basel - SpA MiscellaneousMiscellaneous Part of Smith & Nephew plc, Basel SpA is an Italian company that specializes in medicinal chemicals and botanical products. The company is based in Ravenna, Italy. Basel was acquired by Smith & Nephew plc on April 01, 1995 for $4.80 million. | Corporate Officer/Principal | - |
| ADDEX THERAPEUTICS LTD | Gründer | - |
Ausbildung von Vincent Mutel
| University of Paris Jussieu | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADDEX THERAPEUTICS LTD | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Basel - SpA
Basel - SpA MiscellaneousMiscellaneous Part of Smith & Nephew plc, Basel SpA is an Italian company that specializes in medicinal chemicals and botanical products. The company is based in Ravenna, Italy. Basel was acquired by Smith & Nephew plc on April 01, 1995 for $4.80 million. | Miscellaneous |
CRI Worldwide LLC
CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services CRI Worldwide LLC engages in the provision of inpatient and outpatient clinical research services. It specializes in inpatient and outpatient clinical trials ranging from phase I to IV focusing on pediatrics, adolescents, adults, and elderly in the areas of acute and chronic pain, attention deficit hyperactivity disorder, Alzheimer’s disease, atypical depression, back pain, bipolar disorder, cancer pain, diabetes, epilepsy, fibromyalgia, general anxiety disorder, hepatitis, major depressive disorder, manic depression, migraines/headaches, mild cognitive impairment. The company was founded by Howard A. Hassman in 2000 and is headquartered in Mt. Laurel, NJ. | Commercial Services |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Inflamalps SA
Inflamalps SA Pharmaceuticals: MajorHealth Technology Inflamalps SA operates as a biopharmaceutical company. The firm focuses on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology. The company was founded by Charles Woler, Vincent Mutel and Philippe Meuwly in August 2012 and is headquartered in Monthey, Switzerlands. | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Health Technology |
